September 6, 2017 - By Peter Erickson
Arcadia Biosciences Inc (RKDA) formed wedge down with $0.37 target or 7.00% below today’s $0.40 share price. Arcadia Biosciences Inc (RKDA) has $17.07M valuation. The stock decreased 2.44% or $0.01 on September 5, reaching $0.4. About shares traded. Arcadia Biosciences Inc (NASDAQ:RKDA) has declined 43.32% since September 6, 2016 and is downtrending. It has underperformed by 60.02% the S&P500.
Monro, Inc., formerly Monro Muffler Brake, Inc., is engaged in the provision of automotive undercar repair and tire services in the United States. The company has market cap of $1.60 billion. The Firm provides a range of services on passenger cars, light trucks and vans for brakes; mufflers and exhaust systems, and steering, drive train, suspension and wheel alignment. It has a 26.19 P/E ratio. It also offers tires and routine maintenance services, which include state inspections.
Among 2 analysts covering Arcadia Biosciences (NASDAQ:RKDA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Arcadia Biosciences had 2 analyst reports since May 12, 2017 according to SRatingsIntel. The company was maintained on Friday, July 21 by Piper Jaffray. The rating was downgraded by PiperJaffray on Friday, May 12 to “Neutral”.
Lionstone Capital Management Llc holds 4.78% of its portfolio in Monro Inc for 143,347 shares. Pivot Point Capital Partners Llc owns 118,931 shares or 4.1% of their US portfolio. Moreover, Sg Capital Management Llc has 2.81% invested in the company for 295,908 shares. The New York-based Daruma Capital Management Llc has invested 2.72% in the stock. Diker Management Llc, a New York-based fund reported 81,774 shares.
Ratings analysis reveals 67% of Monro Muffler’s analysts are positive. Out of 3 Wall Street analysts rating Monro Muffler, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $66.0 while the high is $69.0. The stock’s average target of $67.50 is 38.46% above today’s ($48.75) share price. MNRO was included in 3 notes of analysts from August 26, 2016. The firm has “Buy” rating by Gabelli given on Tuesday, January 31. The stock of Monro Inc (NASDAQ:MNRO) earned “Neutral” rating by Northcoast on Thursday, October 27. The rating was initiated by Susquehanna on Friday, August 26 with “Positive”.
The stock increased 0.31% or $0.15 during the last trading session, reaching $48.75. About shares traded. Monro Inc (MNRO) has declined 18.88% since September 6, 2016 and is downtrending. It has underperformed by 35.58% the S&P500.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.